Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study

about

Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder.Atypical antipsychotics and effects on feeding: from mice to men.

P2860

Q38284625-C05E1D33-28A7-43D5-A205-19B036A3ED9C Q38850666-6E66F713-55F1-4A4A-AFDF-0ABC55240162

P2860

Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study

Item

http://www.wikidata.org/entity/Q37060012

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effects of ziprasidone and ola ...... -label comparative pilot study

@en

Effects of ziprasidone and ola ...... label comparative pilot study.

@nl

type

Item

label

Effects of ziprasidone and ola ...... -label comparative pilot study

@en

Effects of ziprasidone and ola ...... label comparative pilot study.

@nl

prefLabel

Effects of ziprasidone and ola ...... -label comparative pilot study

@en

Effects of ziprasidone and ola ...... label comparative pilot study.

@nl

P1476

Effects of ziprasidone and ola ...... -label comparative pilot study

@en

P2093

Jin Pyo Hong

http://www.w3.org/2001/XMLSchema#string

Ki Kyoung Yi

http://www.w3.org/2001/XMLSchema#string

Min-Seon Kim

http://www.w3.org/2001/XMLSchema#string

Subin Park

http://www.w3.org/2001/XMLSchema#string

P2860

Ziprasidone versus other atypical antipsychotics for schizophrenia

Antipsychotic-induced weight gain: a comprehensive research synthesis

The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats

Tolerability of ziprasidone: an expanding perspective.

The impact of antipsychotic drugs on food intake and body weight and on leptin levels in blood and hypothalamic ob-r leptin receptor expression in wistar rats.

Antipsychotic-induced weight gain: a review of the literature.

The CATIE schizophrenia trial: results, impact, controversy.

Metabolic predictors of obesity. Contribution of resting energy expenditure, thermic effect of food, and fuel utilization to four-year weight gain of post-obese and never-obese women.

Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications.

Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics.

P2888

1744-9081-9-27

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1744-9081-9-27

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

250307908

http://www.w3.org/2001/XMLSchema#string

P6179

1019456948

http://www.w3.org/2001/XMLSchema#string

P698

23866300

http://www.w3.org/2001/XMLSchema#string

P932

3729530

http://www.w3.org/2001/XMLSchema#string

Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study

about

P2860

P2860

Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P5875

P6179

P698

P932